Diagnosing Lyme disease is complex. Standard tests do not always provide clear answers. Learn about available procedures and their limitations.
Notice: We are a patient organization, not physicians. This information is for educational purposes and does not replace medical advice.
How the diagnostic journey should ideally proceed – and why many patients give up too early.
The first step is always a thorough evaluation of symptoms, tick bite history, travel history, and the timeline of complaints.
VBCI Note: An experienced clinician evaluates the entire medical history – not just routine blood tests.
ELISA is used as a screening tool, confirmed by Western Blot. This two-tier approach has significant known limitations.
Important: A negative ELISA does NOT rule out Lyme disease. False negatives are common in early stages.
If symptoms persist despite negative standard serology: LTT-Borrelia, CD57+ NK cells, and specialized PCR panels are indicated.
These specialized tests require accredited laboratories – VBCI helps connect patients with verified testing centers.
Diagnosis is a comprehensive clinical synthesis of symptoms, progression, and initial therapy response.
Chronic infections require specialist expertise. VBCI assists with provider guidance.
Not every test fits every case. Key differences at a glance.
Initial screening in conventional healthcare systems
The first step is usually a screening test (ELISA). If positive, confirmation follows via Western Blot.
The limitation: These tests search for antibodies, not the bacteria directly. In early stages or with weakened immunity, patients often do not produce measurable antibodies ('seronegativity'). A negative result does not definitively rule out Lyme disease.
Cellular Assays & Biomarkers
Many specialized physicians utilize advanced testing such as the Lymphocyte Transformation Test (LTT).
LTT: Measures the active T-cell response to Borrelia antigens, providing evidence of active cellular immune confrontation even when antibodies are absent.
CD57+ Test: A specialized natural killer (NK) cell marker frequently suppressed in chronic Lyme disease.
Clinical diagnosis is paramount. Laboratory tests can be false-negative and should always be considered in the context of symptoms.
Experienced Lyme specialists treat patients, not just lab sheets. When clinical presentation strongly indicates Lyme disease, therapy may be justified even without positive standard serology.
View Therapy OptionsIf you meet these criteria, seeking a physician experienced in tick-borne diseases is strongly recommended.
Persistent symptoms despite negative standard lab tests
Clear history of tick exposure with unresolving multi-system complaints
Chronic fatigue, migratory joint pain, or neurological deficits
Fluctuating or progressively worsening symptoms in episodes
Previous standard antibiotic courses failed to achieve sustained recovery
Suspected co-infections (Babesia, Bartonella, Rickettsia)
This scientific information is provided for educational and patient guidance purposes only. It does not constitute medical advice, individualized diagnosis, or a promise of cure, and cannot replace a personal consultation with a qualified physician.
Association for the Treatment of Chronic Infections (VBCI e.V.) – Non-Profit Patient Organization.
Chronic infections require in-depth knowledge and individual solutions. Our experts guide you toward the right diagnosis.
When you contact us, we treat your data confidentially. Please read our privacy policy regarding the processing of personal data. By contacting us, you agree to this.
Specialized physicians, environmental medicine clinics, and accredited laboratories
Specialized Diagnostics: EliSpot, Lyme LTT, CD57+ NK cells, Co-infections
Accredited Lab: Lymphocyte Transformation Test (LTT), Cytokine profiles, Autoimmunity
Multimodal Lyme & CFS Treatment, Infusion Protocols, Biofilm Management
Interdisciplinary Chronic Illness Care, Neuroborreliosis, Mitochondrial Medicine
Specialist Clinic for Tick-Borne Diseases, CFS/ME Differential Diagnosis, Long-COVID
Independent Patient Advocacy, Second Opinion Guidance, Clinical Resources